Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 129791 | Euronext NV (ENX.F) | XFRA | NL | 2023-12-31 | 1 week ago | EUR | 16.10 | 60.54 | 376.05% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 129792 | European Biotech Acquisition Corp (7DQ0.F) | XFRA | NL | 2021-12-31 | 1 year ago | USD | 0.00 | 4.27 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 129793 | European Biotech Acquisition Corp (7DQ.F) | XFRA | NL | 2021-12-31 | 1 year ago | USD | 0.00 | 4.27 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 129794 | PB Holding N.V. (PBH.AS) | XAMS | NL | 2022-12-31 | 4 days ago | EUR | 2.88 | 0.00 | 0.00% | 0.23 | 7.95% | NCAV (Net-Net) | 0.23 | 7.95% |
| 129795 | European Biotech Acquisition Corp (EBACU) | XNAS | NL | 2021-12-31 | 1 year ago | USD | 10.17 | 4.27 | 42.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 129796 | European Biotech Acquisition Corp (EBAC) | XNAS | NL | 2021-12-31 | 1 year ago | USD | 9.81 | 4.27 | 43.54% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 129797 | ABN Amro Bank NV (AB2A.F) | XFRA | NL | 2023-12-31 | 4 days ago | EUR | 14.70 | 35.92 | 244.32% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 129798 | Adyen NV (1N8.HA) | XHAN | NL | 2023-12-31 | 3 hours ago | EUR | 1,135.20 | 206.30 | 18.17% | 84.62 | 7.45% | NCAV (Net-Net) | 84.62 | 7.45% |
| 129799 | Aegon Ltd (AEND.HA) | XHAN | NL | 2022-12-31 | 6 months ago | EUR | 4.50 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 129800 | NXP Semiconductors NV (VNX.HA) | XHAN | NL | 2023-12-31 | 3 hours ago | USD | 0.00 | 84.07 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |